Riskpilot← Back to searchSign inGet full accessSkår Göteborg Psykiatri AB
ABActiveOrg 5567576441Hallongången 1Medical specialists activities · NACE 8622Est. 20080 employees
Revenue 2025
SEK 37K
-56% vs 2024
EBITDA margin
-19.2%
-114% vs 2024
Equity ratio
91.6%
Financial strength
Net profit 2025
SEK -6K
-116% vs 2024
| Revenue | SEK 37K | -56% |
| EBITDA | SEK -7K | -114% |
| Net profit | SEK -6K | -116% |
| Total assets | SEK 192K | -9% |
| Equity | SEK 176K | -3% |
| Employees | 0 | — |
Legal name
Skår Göteborg Psykiatri AB
Org number
5567576441
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 maj 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet ska vara psykiatrisk rådgivning, föreläsnings- och kursverksamhet samt därmed förenlig verksamhet. Bolaget ska också kunna ägna sig åt att äga och förvalta värdepapper.
Address
Hallongången 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 26 | 61 | 28 | 83 | 37 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −6 | 26 | −2 | 50 | −7 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −6 | 26 | −2 | 50 | −7 |
| Net financials | — | −0 | 0 | 1 | 1 |
| Profit before tax | −6 | 26 | −2 | 51 | −6 |
| Tax | −0 | −5 | — | −11 | — |
| Net profit | −6 | 21 | −2 | 40 | −6 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 168 | 188 | 184 | 212 | 192 |
| Equity | 124 | 145 | 143 | 182 | 176 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 44 | 43 | 41 | 29 | 16 |
| Total debt | 44 | 43 | 41 | 29 | 16 |
EBITDA margin
-19.2%
This company
15.8%
Market median
-222% vs market
20212025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20212025
Return on equity
-3.6%
This company
18.4%
Market median
-120% vs market
20212025
Net profit margin
-17.1%
This company
8.1%
Market median
-311% vs market
20212025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Skår Göteborg Psykiatri AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Elisabet Marianne Wentz | Board of Directors | 0 companies |
| Andrea Elisabet Nilsson | Deputy Board Member | 0 companies |
| Nils Olof Wentz | Deputy Board Member | 0 companies |